Navigation Links
Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta
Date:8/5/2008

ns except for the four endocrine hormones licensed to Schering-Plough.

ABOUT MODIGENE

Modigene Inc. is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta and erythropoietin, which are in late preclinical development, as well as GLP-1. For more information on Modigene, visit http://www.modigeneinc.com.

Safe Harbor Statement: This press release contains forward-looking statements, including statements regarding the results of current studies and preclinical experiments and the effectiveness of Modigene's long-acting protein programs and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect Modigene's business and prospects, including the risks that Modigene may not succeed in developing any commercial products based upon its long-acting protein technology, including any long-acting versions of human growth hormone, erythropoietin, interferon beta or GLP-1; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; that the actual dollar amount of any grants from the OCS is uncertain and is subject to policy changes of the Israeli government, and that such grants may be insufficient to assist with product development; and other risks and uncertaint
'/>"/>

SOURCE Modigene Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Modigene Platform Validated in Independent Phase III Trial of CTP Technology
2. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
3. GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer
4. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
5. Discovering How Video Games Can Motivate Healthy Behaviors: More than $2 Million Awarded to 12 Research Teams Across U.S.
6. TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
7. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
8. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
9. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
10. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
11. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... NASHVILLE, Tenn. and GLEN ROCK, N.J., Dec. 15 ... 70 percent of surveyed pharmacy directors expect to ... the treatment of chronic pain. Tanezumab, which is ... chronic pain and is administered intravenously under medical ... benefit rather than a pharmacy benefit according to ...
(Date:12/15/2009)... Accumetrics, Inc., developer and marketer of ... diagnostic system for measuring an individual,s response to ... doubling in the number of international and U.S. ... support, and significant capital financing that will take ... the company continued its commitment to creating a ...
(Date:12/14/2009)... Dec. 14 BioTrends Research Group, Inc. ... a syndicated publication offering comprehensive insight into the ... based on a comparison of self-reported treatment approaches ... level data for over 1,000 RA patients who ... To be eligible for the audit, patients had ...
Breaking Medicine Technology:Majority of Surveyed Pharmacy Directors Expect To Cover Pfizer's Tanezumab If It Is Approved for the Treatment of Chronic Pain 2Majority of Surveyed Pharmacy Directors Expect To Cover Pfizer's Tanezumab If It Is Approved for the Treatment of Chronic Pain 3Accumetrics Closes 2009 with Positive Outlook 2Accumetrics Closes 2009 with Positive Outlook 3New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 2New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 3PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 1PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 2PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 3PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 4PAREXEL Introduces The Expert Office 28TM 29 Offering Enhanced Access to Comprehensive Expertise to Meet Strategic Partnering Needs 60751 5LenSar 3A New Laser Cure for Cataracts 6005 1LenSar 3A New Laser Cure for Cataracts 6005 2Superior Global Solutions Inc Acquires HTI Technologies Inc 60747 1Superior Global Solutions Inc Acquires HTI Technologies Inc 60747 2
(Date:12/15/2009)... combined with developmental changes increases risk in teens, study ... teenagers, being overweight or obese increases the risk of ... to be true for younger children, Australian researchers have ... children, aged 2 to 18, who were referred for ... researchers found that among those aged 12 and older ...
(Date:12/15/2009)... within a week of getting news, researchers say ... stress can put newly diagnosed prostate cancer patients ... a new study has found. , Researchers analyzed ... cancer between 1961 and 2004. Of those men, ... a year of cancer diagnosis and 136 (0.08 ...
(Date:12/15/2009)... Dec. 15 Mergers and acquisitions are ... their reach globally or complete a product portfolio ... integration of safety programs. ,, A new free, ... Practices in a Hearing Conservation Program: US Airways ... and America West led the newly formed company ...
(Date:12/15/2009)... Ga., Dec. 15 Hosted by the ... 4th annual event recognized 2009,s best eLearning designs. ... were spread across 4 categories. The Venza ... for the world,s largest hotelier, was selected as ... of Custom eLearning" category by the panel of ...
(Date:12/15/2009)... cells may offer a new option to treat about ... amplified signaling of the epidermal growth factor receptor (EGFR), ... Jonsson Comprehensive Cancer Center. , Rapidly dividing cancer cells ... The fatty acids also provide an alternative energy source ... regulating cell signaling, said Dr. Paul Mischel, a professor ...
Breaking Medicine News(10 mins):Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 2Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 3Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 4Health News:The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 2Health News:Targeting brain cancer cell metabolism may provide new treatment 2Health News:Targeting brain cancer cell metabolism may provide new treatment 3
... manufacture plentiful anti-flu drugs at a cheaper cost. Tamiflu is ... method while relaxing at home on a weekend. // The ... to World Health Organization to prevent any outbreak of the ... cycle is a compound extracted from the plant star anise. ...
... Medical Council of India (MCI) has condemned the poor infrastructure, ... Agartala Medical College. // ,The (MCI) delegation, headed ... of this government-run college and its failure to set up ... The non-completion of the college building was another factor of ...
... London, England Patricia Rashbrook, a child psychologist from Lewes, ... is 63-years-old and would become the world’s oldest mother. ... in an unnamed former Soviet republic because Italy has ... was perfect candidate for the treatment. Rashbrook’s said that ...
... epidemic of bird flu there would be insufficient supply of ... has asked the drug companies to come up with vaccines ... It has roped in 5 companies to solve the problem. ... with better influenza vaccines. GlaxoSmithKline was awarded $274.75 million, MedImmune ...
... North America. Recently there is an increase in the number ... contagious skin infection. Scalp ringworm result in a number ... which can be permanent if left untreated. Usually they are ... passed easily between people. , Statistics by the ...
... the son of a Hamilton firefighter who died of cancer ... to extend workers compensation //scheme to firefighters as well. Shaw ... package for industrial diseases. ,New Democrat Andrea Horvath ... Bob Shaw, Nathan's father spent four days fighting the Plastimet ...
Other Medicine News:
BD Beaver DeBakey blade, 5 mm cutting width, sterile....
... They are made of optical quality acrylic and are ... two sets available providing a full range of prisms. ... patient can wear the prism with the trial frame ... adapt to the use of the prism. Patient feedback ...
Developed for reconstructive plastic surgery with E-Type coupling. Order blades by size from 12 mm, 25 mm, 50 mm or 75 mm depending on your specific case requirements. Blades come in packs of 10....
Corneal rust ring remover battery powered, extra burr 1.0 mm....
Medicine Products: